← Leaderboards
Andrew R Draganski
Zylo Therapeutics, Inc.
$2,678,047
Attributed
$3,387,421
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,387,421 · 6
By mechanism
R44$1,705,226 · 1
R41$1,682,195 · 5
Top collaborators
- Joshua D Nosanchuk2 shared
- Victoria P Werth2 shared
- Waleed M Abuzeid1 shared
- Kelvin P Davies1 shared
Most similar at Zylo Therapeutics, Inc.
Same institution · by research overlap
- Waleed M Abuzeid$150,000
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseTopical ApplicationFormulationSafety StudyTissuesNitric OxideSilicon DioxideQuality Of LifeAffectParticlePharmaceutical PreparationsNovel TherapeuticsFda ApprovedIn VivoPhase 1 StudyPrototypeClinical TranslationEfficacy StudyPenetrationGenerationsBaseIn VitroOperative Surgical ProceduresAging
Grant awards (9)
Development and optimization of a nitric oxide releasing microparticle formulation for the topical treatment of chronic rhinosinusitis$300,000
R41 · FY2025 · AI · contact PI
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.$145,888
R41 · FY2024 · AR · contact PI
Development and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis$300,000
R41 · FY2023 · AI · contact PI
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.$147,861
R41 · FY2023 · AR · contact PI
Development of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors$1,008,058
R44 · FY2022 · DK · contact PI
Development and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis$300,000
R41 · FY2022 · AI · contact PI
Optimization of a nanoparticle-based topical PDE5i formulation for treatment of erectile dysfunction$263,446
R41 · FY2022 · DK · contact PI
Development of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors$697,168
R44 · FY2021 · DK · contact PI
Optimization of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors$225,000
R41 · FY2019 · DK · contact PI